MEK162 for Patients With RAS/RAF/MEK Activated Tumors

Clinical trial NCT01885195 · COMPLETED

Trial details

NCT number: NCT01885195
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor and Hematologic Malignancies

Start date: 2013-10-10
Primary completion: 2015-10-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.